The company has been committed to solving unmet clinical needs, focusing on the development of innovative drugs and new therapeutic technologies with global value. Relying on various innovative R&D platforms and research institutions, the company has steadily built its core competitiveness in the fields of characteristic API, high-end generic drugs, innovative drugs and novel drug delivery system.
On-going Research Projects
Pipeline of Innovative Product Candidates
R&D Staff
Proportion for R&D Staff with over Master Degree(approx)
Characteristic API
Technology Platforms
CMC Innovative R&D Platform for Green API
Crystal Research Platform
Contrast Agent Development
High-end Generic Drugs
Technology Platforms
Complex Pharmaceutical Innovation Technology
Insoluble Drug Development
Fermentation Semi-synthesis Drug Development
Particulate Technology
Radiopharmaceutical Localization
Innovative Drugs
Technology Platforms
Cell and Gene Therapy
Multi Antibody Development
Prodrug Fusion
Antibody Drug Conjugate(ADC)
Nanodelivery Development
Radiopharmaceutical Development
Oligonucleotide Drug Development
LBPs Development
Innovative Chinese Medicine Development
Novel Drug Delivery System
Technology Platforms
Particulate Technology
Frontier Delivery Technology (Nose-to-Brain Delivery Technology)
Innovative Drug Delivery Device
In-Vitro In-Vivo Correlation
R&D Platforms
R&D Institutions
R&D Talents
The company values the introduction and cultivation of innovative talent, has a well-established talent incentive mechanism, and integrates talent development with its strategic direction in science and technology to enable them to fully exercise their innovative abilities and meet the needs of the company, the industry, and society
Intellectual Property
Patent Applications
Domestic Authorized Patents
Overseas Patent Applications
Overseas Authorized Patents